Journal Information
Vol. 89. Issue 1.
Pages 42-43 (January 2014)
Share
Download PDF
More article options
Vol. 89. Issue 1.
Pages 42-43 (January 2014)
Letter to the Editor
Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab
Experiencia inicial con aflibercept intravítreo en la degeneración macular asociada a la edad exudativa refractaria al tratamiento con ranibizumab o bevacizumab
Visits
967
R.E. Cervera
, V. Castro, J. Montero, C. Torralba, A. Gracia
Corresponding author
Servicio de Oftalmología, Hospital General Universitario, Valencia, Spain
This item has received
Article information
These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail